Guardian Pharmacy Services (GRDN) vs PetMed Express (PETS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Guardian Pharmacy Services (GRDN) has outperformed PetMed Express (PETS) over the past year, gaining 65.5% versus a loss of 47.2%. Guardian Pharmacy Services is the larger company by market cap ($2.97 billion vs $18.9 million), about 157.4 times the size. Guardian Pharmacy Services converts more of its revenue into profit, with a net margin of 3.4% versus -32.0%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | GRDN | PETS |
|---|---|---|
| Share price | $46.94 | $0.8501 |
| Market cap | $2.97B | $18.90M |
| 1-day change | +0.58% | -8.04% |
| YTD return | +56.00% | -73.43% |
| 1-year return | +65.51% | -47.20% |
| 5-year return | — | -97.07% |
| P/E ratio (TTM) | 40.12 | — |
| Forward P/E | 31.26 | — |
| EPS (TTM) | $1.17 | $-1.29 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $1.45B | $179.02M |
| Revenue growth (YoY) | +17.93% | -21.13% |
| Net income (latest FY) | $49.22M | $-57.29M |
| Gross margin | 20.21% | 28.05% |
| Operating margin | 5.02% | -32.77% |
| Net margin | 3.40% | -32.00% |
| 52-week high | $50.85 | $4.10 |
| 52-week low | $26.34 | $0.8466 |
| Distance from 52-week high | -7.69% | -79.27% |
| Analyst consensus | strong_buy | sell |
| Avg. price target upside | +6.82% | +64.69% |
| Average volume | 547.39K | 118.20K |
| Shares outstanding | 63.32M | 22.23M |
| Employees | 3,600 | 189 |
| Sector | Consumer Staples | Consumer Staples |
| Industry | Retail-Drug Stores and Proprietary Stores | Retail-Drug Stores and Proprietary Stores |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Guardian Pharmacy Services is about 157.4 times larger than PetMed Express by market value ($2.97B vs $18.90M).
- GRDN has outperformed PETS by 112.7 percentage points over the past year.
- Guardian Pharmacy Services is more profitable, keeping 3.4 cents of every revenue dollar as net income versus -32.0 cents for PetMed Express.
- Guardian Pharmacy Services grew revenue faster in its latest fiscal year (+17.93% vs -21.13%).
About Guardian Pharmacy Services
GRDN stock →Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. The company's individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities, behavioral health facilities, and group homes.
Consumer Staples · Retail-Drug Stores and Proprietary Stores · 3,600 employees
About PetMed Express
PETS stock →PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses.
Consumer Staples · Retail-Drug Stores and Proprietary Stores · 189 employees
GRDN vs PETS FAQ
Which is bigger, Guardian Pharmacy Services or PetMed Express?
Guardian Pharmacy Services (GRDN) is larger, with a market capitalization of $2.97B compared with $18.90M for PetMed Express (PETS).
Which stock has performed better over the past year, GRDN or PETS?
GRDN returned +65.51% over the past 12 months, compared with -47.20% for PETS (price return, excluding dividends). Past performance does not predict future results.
Are Guardian Pharmacy Services and PetMed Express in the same industry?
Yes. Both are classified in the Retail-Drug Stores and Proprietary Stores industry within the Consumer Staples sector.